Recital 27, Commission Regulation (EC) No 983/2009 of 21 October 2009 on the authorisation and refus…

In forcesince 21 Oct 2009

Following an application from Martek Biosciences Corporation submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of docosahexaenoic acid (DHA) and arachidonic acid (ARA) on neural development of the brain and eyes (Question No EFSA-Q-2008-120) [The EFSA Journal (2008) 794, 1-2.]. The claim proposed by the applicant was worded as follows: ‘DHA and ARA support neural development of the brain and eyes’.